Article Details
Retrieved on: 2024-02-03 20:35:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The brokerage currently has an “overweight” rating on the biotechnology company's stock. Piper Sandler's target price points to a potential upside of ...
Article found on: www.defenseworld.net
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here